Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

MAY 09, 2016 - Investors Business Daily

A Must Read - Share

MAY 09, 2016 - Yahoo! News

A Must Read - Share

Exclusive: Medivation succumbs to pressure to explore sale -sources

U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the ...

Tags: Exclusive: Medivation succumbs to pressure to explore sale -sources,  Pfizer Latest News

MAY 09, 2016 - TheStreet

A Must Read - Share

AAPL, AMZN, SQ: Jim Cramer's Views

Jim Cramer shares his views every day on RealMoney. Click here for a real-time look at his insights and musings. Cramer: Collateral Damage Is Giving These Stocks a Bad Name Posted at 12:47 p.m. EDT on Friday, May 06, 2016 Sure the employment number wasn't that strong. Yes there's a bit of a slowdown. But, oddly, we have panic moves ...

Tags: AAPL, AMZN, SQ: Jim Cramer's Views,  Pfizer Latest News

MAY 06, 2016 - Business Insider

A Must Read - Share

DAN LOEB: 'We're in a market where people have very itchy trigger fingers' (TPRE)

Hedge funds have been taking a hammering. Third Point's Dan Loeb described the start of this year as "one of the most catastrophic periods of hedge fund performance" in his first-quarter letter. But there is opportunity amid the carnage, according to the fund manager. Speaking on Friday on an earnings call for Third Point Reinsurance, Loeb said that while the company was ...

Tags: DAN LOEB: 'We're in a market where people have very itchy trigger fingers' (TPRE),  Pfizer Latest News

MAY 05, 2016 - DealBook

A Must Read - Share

Breakingviews: Pfizer Needs Clearer Goals

As the drug-giant weighs its options, setting a strategy would be better than keeping all doors open.

Tags: Breakingviews: Pfizer Needs Clearer Goals,  Pfizer Latest News